Paper42755095
MAGEA Family Gene Expression Influences Survival in Intestinal-Type Gastric Cancer.
Neumann S and 4 others. Cancer Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. MAGEA Family Gene Expression Influences Survival in Intestinal-Type Gastric Cancer. Papers, record 42755095. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42755095
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Stomach Neoplasms | Major topic |
| Antigens, Neoplasm | Major topic |
| Neoplasm Proteins | Major topic |
| Humans | |
| Male | |
| Female | |
| Prognosis | |
| Biomarkers, Tumor | |
| Gene Expression Regulation, Neoplastic | |
| Middle Aged | |
| Aged | |
| Gene Expression Profiling | |
| Aged, 80 and over | |
| Adult |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| ID288714 | National Health and Medical Research Council | PubMed | PubMed | ||
| ID454584 | National Health and Medical Research Council | PubMed | PubMed | ||
| ID570996 | Cancer Australia | PubMed | PubMed | ||
| IDAPP1030980 | Peter MacCallum Foundation | IDAPP103098 | PubMed | NIH RePORTER |
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21684283 | Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. | Gastroenterology | 2011 | https://conductscience.org/library/papers/21684283 | PubMed |
| 2 | 28647208 | MAGE-A family is involved in gastric cancer progression and indicates poor prognosis of gastric cancer patients. | Pathol Res Pract | 2017 | https://conductscience.org/library/papers/28647208 | PubMed |
| 3 | 27384994 | Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. | Oncotarget | 2016 | https://conductscience.org/library/papers/27384994 | PubMed |
| 4 | 36999473 | Research progress in effects of MAGE-A family on gastric cancer. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2023 | https://conductscience.org/library/papers/36999473 | PubMed |
| 5 | 7927540 | Structure, chromosomal localization, and expression of 12 genes of the MAGE family. | Immunogenetics | 1994 | https://conductscience.org/library/papers/7927540 | PubMed |
| 6 | 34970496 | Comprehensive Analysis to Identify MAGEA3 Expression Correlated With Immune Infiltrates and Lymph Node Metastasis in Gastric Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34970496 | PubMed |
| 7 | 21725411 | Gastric cancer location and histological subtype in Pacific people and Māori defies international trends. | N Z Med J | 2011 | https://conductscience.org/library/papers/21725411 | PubMed |
| 8 | 23684942 | Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. | Gastroenterology | 2013 | https://conductscience.org/library/papers/23684942 | PubMed |
| 9 | 23193258 | NCBI GEO: archive for functional genomics data sets--update. | Nucleic Acids Res | 2013 | https://conductscience.org/library/papers/23193258 | PubMed |
| 10 | 33460964 | Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials. | ESMO Open | 2021 | https://conductscience.org/library/papers/33460964 | PubMed |
| 11 | 21430069 | Molecular classification of gastric cancer: a new paradigm. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21430069 | PubMed |
| 12 | 12925757 | Variation in gene expression patterns in human gastric cancers. | Mol Biol Cell | 2003 | https://conductscience.org/library/papers/12925757 | PubMed |
| 13 | 34468869 | Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial. | Gastric Cancer | 2022 | https://conductscience.org/library/papers/34468869 | PubMed |
| 14 | 38554725 | Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. | Lancet | 2024 | https://conductscience.org/library/papers/38554725 | PubMed |
| 15 | 33070127 | DNA Methylation and Genetic Aberrations in Gastric Cancer. | Digestion | 2021 | https://conductscience.org/library/papers/33070127 | PubMed |
| 16 | 35030335 | Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. | Lancet Oncol | 2022 | https://conductscience.org/library/papers/35030335 | PubMed |
| 17 | 28922362 | Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer. | PLoS One | 2017 | https://conductscience.org/library/papers/28922362 | PubMed |
| 18 | 32754227 | A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer. | Ther Adv Med Oncol | 2020 | https://conductscience.org/library/papers/32754227 | PubMed |
| 19 | 29908991 | MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. | Lancet Oncol | 2018 | https://conductscience.org/library/papers/29908991 | PubMed |
| 20 | 25894828 | Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. | Nat Med | 2015 | https://conductscience.org/library/papers/25894828 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42755095
GET https://conductscience.org/api/papers/v1/42755095/references?page=2